| Literature DB >> 25147049 |
Dinglin Zhang1, Yanling Wei, Kai Chen, Xiangjun Zhang, Xiaoqiu Xu, Qing Shi, Songling Han, Xin Chen, Hao Gong, Xiaohui Li, Jianxiang Zhang.
Abstract
A novel reactive oxygen species (ROS)-responsive nanoplatform can be successfully manufactured from a ROS-triggerable β-cyclodextrin material. Extensive in vitro and in vivo studies validate that this nanoscaled system may serve as a new drug delivery vehicle with well-defined ROS-sensitivity and superior biocompatibility. This nanocarrier can be used for ROS-triggered transport of diverse therapeutics and imaging agents.Entities:
Keywords: ROS-responsiveness; cyclodextrin; drug delivery; nanomedicine; tumor targeting
Mesh:
Substances:
Year: 2014 PMID: 25147049 DOI: 10.1002/adhm.201400299
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933